Keros Therapeutics (KROS) Insider Trading
Officer, director, and 10%+ owner transactions reported to the SEC on Form 4, with buy/sell totals and cluster activity for Keros Therapeutics.
Bought (12 mo)
$75,770
Sold (12 mo)
$522,951
Insiders Buying (12 mo)
1
Insiders Selling (12 mo)
9
Form 4 Filings (All Time)
156
Most Recent Purchase
August 19, 2026
Jean Jacques Bienaime
Director
$10,270
Most Recent Sale
August 20, 2026
Annita Tanini
VP
$12,595
Buys (90d)
1
Sells (90d)
4
Recent Insider Transactions
| Filed | Insider | Role | Type | Value | % Change |
|---|---|---|---|---|---|
| 2026-08-20 | Tanini Annita | Officer | Sell | $12,595 | -2.6% |
| 2026-08-20 | Cho Esther | Officer | Sell | $46,151 | -11.1% |
| 2026-08-20 | Lerner Lorena Raquel | Officer | Sell | $36,715 | -11.5% |
| 2026-08-20 | Newton Charles W. | Director | Sell | $5,675 | -4.4% |
| 2026-08-19 | Bienaime Jean Jacques | Director | Buy | $10,270 | +5.4% |
Sign up free to view more insider trades.